#1501 - While analysts still see strong potential in the biotech sector, they also acknowledge that life sciences industry is in an era of significant transition. What does this mean for biotechnology companies? Will the industry continue to expand? Will M&A pressure blur the lines between biotechnology and pharmaceuticals even further? What skills do leaders need to shape the biotechnology companies of the future? We discuss the changing landscape of the biotechnology industry with President and CEO of Pennsylvania Bio, Chris Molineaux.Read more ›